Advanced company searchLink opens in new window

AKAMIS BIO LIMITED

Company number 06001442

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Nov 2024 RP04SH01 Second filing of a statement of capital following an allotment of shares on 17 October 2024
  • GBP 66,722.93
04 Nov 2024 AP01 Appointment of Dr Christopher Bowden as a director on 28 October 2024
04 Nov 2024 PSC09 Withdrawal of a person with significant control statement on 4 November 2024
27 Oct 2024 MA Memorandum and Articles of Association
27 Oct 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES12 ‐ Resolution of varying share rights or name
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
23 Oct 2024 SH01 Statement of capital following an allotment of shares on 17 October 2024
  • GBP 66,722.93
  • ANNOTATION Clarification a second filed SH01 was registered on 06/11/24.
22 Oct 2024 SH10 Particulars of variation of rights attached to shares
22 Oct 2024 SH08 Change of share class name or designation
18 Oct 2024 TM01 Termination of appointment of Robin Lewis Lincoln as a director on 17 October 2024
18 Oct 2024 TM01 Termination of appointment of Christopher Bowden as a director on 17 October 2024
18 Oct 2024 TM01 Termination of appointment of Ip2Ipo Services Limited as a director on 17 October 2024
18 Oct 2024 TM01 Termination of appointment of J. Duncan Higgons as a director on 17 October 2024
18 Oct 2024 TM01 Termination of appointment of Lars Gredsted as a director on 17 October 2024
18 Oct 2024 TM01 Termination of appointment of Matthew Foy as a director on 17 October 2024
18 Oct 2024 AP01 Appointment of Richard Nan Shen as a director on 17 October 2024
18 Oct 2024 AP01 Appointment of Adrian Kin Fei Chan as a director on 17 October 2024
04 Jul 2024 MR04 Satisfaction of charge 1 in full
14 Jun 2024 SH01 Statement of capital following an allotment of shares on 11 June 2024
  • GBP 39,047.66
12 Apr 2024 RESOLUTIONS Resolutions
  • RES13 ‐ That, the requirements of the act as to approval of any liability limitation agreement (as defined in section 534 of the act) for the financial year ending 31 december 2023 in accordnace with section 536(2)(a) ofthe act be and hereby waived 04/04/2024
  • RES10 ‐ Resolution of allotment of securities
02 Apr 2024 RP04SH01 Second filing of a statement of capital following an allotment of shares on 8 October 2023
  • GBP 38,958.46
02 Apr 2024 RP04SH01 Second filing of a statement of capital following an allotment of shares on 12 September 2023
  • GBP 35,492.95
05 Feb 2024 CS01 Confirmation statement made on 2 February 2024 with updates
18 Jan 2024 SH01 Statement of capital following an allotment of shares on 11 December 2023
  • GBP 39,012.86
06 Nov 2023 TM01 Termination of appointment of Ezra Cohen as a director on 30 September 2023
10 Oct 2023 SH01 Statement of capital following an allotment of shares on 8 October 2023
  • GBP 38,945.76
  • ANNOTATION Clarification a second filed SH01 was registered on 02/04/2024.